49 related articles for article (PubMed ID: 25973068)
21. Clinicopathological and prognostic significance of Bmi-1 expression in human cervical cancer.
Min L; Dong-Xiang S; Xiao-Tong G; Ting G; Xiao-Dong C
Acta Obstet Gynecol Scand; 2011 Jul; 90(7):737-45. PubMed ID: 21309753
[TBL] [Abstract][Full Text] [Related]
22. Lgr5 over-expression is positively related to the tumor progression and HER2 expression in stage pTNM IV colorectal cancer.
Gao FJ; Chen JY; Wu HY; Shi J; Chen M; Fan XS; Huang Q
Int J Clin Exp Pathol; 2014; 7(4):1572-9. PubMed ID: 24817953
[TBL] [Abstract][Full Text] [Related]
23. Intestinal stem cell marker LGR5 expression during gastric carcinogenesis.
Zheng ZX; Sun Y; Bu ZD; Zhang LH; Li ZY; Wu AW; Wu XJ; Wang XH; Cheng XJ; Xing XF; Du H; Ji JF
World J Gastroenterol; 2013 Dec; 19(46):8714-21. PubMed ID: 24379591
[TBL] [Abstract][Full Text] [Related]
24. Over-expression of LGR5 correlates with poor survival of colon cancer in mice as well as in patients.
Liu Z; Dai W; Jiang L; Cheng Y
Neoplasma; 2014; 61(2):177-85. PubMed ID: 24063790
[TBL] [Abstract][Full Text] [Related]
25. The clinicopathological significance of Lgr5 expression in lung adenocarcinoma.
Ryuge S; Sato Y; Jiang SX; Wang G; Kobayashi M; Nagashio R; Katono K; Iyoda A; Satoh Y; Masuda N
Lung Cancer; 2013 Oct; 82(1):143-8. PubMed ID: 23915911
[TBL] [Abstract][Full Text] [Related]
26. LGR5 is a promising biomarker for patients with stage I and II gastric cancer.
Bu Z; Zheng Z; Zhang L; Li Z; Sun Y; Dong B; Wu A; Wu X; Wang X; Cheng X; Xing X; Li Y; Du H; Ji J
Chin J Cancer Res; 2013 Feb; 25(1):79-89. PubMed ID: 23372345
[TBL] [Abstract][Full Text] [Related]
27. Lgr5 is a potential marker of colorectal carcinoma stem cells that correlates with patient survival.
Wu XS; Xi HQ; Chen L
World J Surg Oncol; 2012 Nov; 10():244. PubMed ID: 23153436
[TBL] [Abstract][Full Text] [Related]
28. Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Colombo N; Carinelli S; Colombo A; Marini C; Rollo D; Sessa C;
Ann Oncol; 2012 Oct; 23 Suppl 7():vii27-32. PubMed ID: 22997451
[No Abstract] [Full Text] [Related]
29. Significant correlation between LKB1 and LGR5 gene expression and the association with poor recurrence-free survival in rectal cancer after preoperative chemoradiotherapy.
Saigusa S; Inoue Y; Tanaka K; Toiyama Y; Kawamura M; Okugawa Y; Okigami M; Hiro J; Uchida K; Mohri Y; Kusunoki M
J Cancer Res Clin Oncol; 2013 Jan; 139(1):131-8. PubMed ID: 22986809
[TBL] [Abstract][Full Text] [Related]
30. Measurement of aldehyde dehydrogenase 1 expression defines a group with better prognosis in patients with non-small cell lung cancer.
Dimou A; Neumeister V; Agarwal S; Anagnostou V; Syrigos K; Rimm DL
Am J Pathol; 2012 Oct; 181(4):1436-42. PubMed ID: 22877687
[TBL] [Abstract][Full Text] [Related]
31. CD44+/CD24- ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival.
Meng E; Long B; Sullivan P; McClellan S; Finan MA; Reed E; Shevde L; Rocconi RP
Clin Exp Metastasis; 2012 Dec; 29(8):939-48. PubMed ID: 22610780
[TBL] [Abstract][Full Text] [Related]
32. The spatial distribution of LGR5+ cells correlates with gastric cancer progression.
Simon E; Petke D; Böger C; Behrens HM; Warneke V; Ebert M; Röcken C
PLoS One; 2012; 7(4):e35486. PubMed ID: 22530031
[TBL] [Abstract][Full Text] [Related]
33. Mutations in the Ras-Raf Axis underlie the prognostic value of CD133 in colorectal cancer.
Kemper K; Versloot M; Cameron K; Colak S; de Sousa e Melo F; de Jong JH; Bleackley J; Vermeulen L; Versteeg R; Koster J; Medema JP
Clin Cancer Res; 2012 Jun; 18(11):3132-41. PubMed ID: 22496204
[TBL] [Abstract][Full Text] [Related]
34. Tumorigenesis: Testing ground for cancer stem cells.
Delude C
Nature; 2011 Dec; 480(7377):S43-5. PubMed ID: 22169801
[No Abstract] [Full Text] [Related]
35. Expression of the adult intestinal stem cell marker Lgr5 in the metastatic cascade of colorectal cancer.
Kleist B; Xu L; Li G; Kersten C
Int J Clin Exp Pathol; 2011 Apr; 4(4):327-35. PubMed ID: 21577318
[TBL] [Abstract][Full Text] [Related]
36. Worldwide burden of cervical cancer in 2008.
Arbyn M; Castellsagué X; de Sanjosé S; Bruni L; Saraiya M; Bray F; Ferlay J
Ann Oncol; 2011 Dec; 22(12):2675-2686. PubMed ID: 21471563
[TBL] [Abstract][Full Text] [Related]
37. Expression of LGR5, an intestinal stem cell marker, during each stage of colorectal tumorigenesis.
Takeda K; Kinoshita I; Shimizu Y; Matsuno Y; Shichinohe T; Dosaka-Akita H
Anticancer Res; 2011 Jan; 31(1):263-70. PubMed ID: 21273608
[TBL] [Abstract][Full Text] [Related]
38. Colon cancer stem cells: implications in carcinogenesis.
Sanders MA; Majumdar AP
Front Biosci (Landmark Ed); 2011 Jan; 16(5):1651-62. PubMed ID: 21196254
[TBL] [Abstract][Full Text] [Related]
39. LGR5 deficiency deregulates Wnt signaling and leads to precocious Paneth cell differentiation in the fetal intestine.
Garcia MI; Ghiani M; Lefort A; Libert F; Strollo S; Vassart G
Dev Biol; 2009 Jul; 331(1):58-67. PubMed ID: 19394326
[TBL] [Abstract][Full Text] [Related]
40. A stochastic model for cancer stem cell origin in metastatic colon cancer.
Odoux C; Fohrer H; Hoppo T; Guzik L; Stolz DB; Lewis DW; Gollin SM; Gamblin TC; Geller DA; Lagasse E
Cancer Res; 2008 Sep; 68(17):6932-41. PubMed ID: 18757407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
